Radiation Injury Drugs Market

Global Radiation Injury Drugs Market Size, Share & Trends Analysis Report, By Type (Aerosurf, BMX-001, C-2E2, C-2E5, Des-Asp Angiotensin 1, DG-3, and Others), By Application (Ambulatory Surgical Centers, Hospitals and Clinics, and Others), Forecast (2022-2028)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2026122 | Category : Healthcare Information Technology | Delivery Format: /

The global radiation injury drugs market is anticipated to grow at a significant CAGR 4.5% during the forecast period (2022-2028). Radiation injury is defined as the damage of tissues due to exposure of ionizing radiation. The ionizing radiation given in large dose may injure the healthy human cells and even result in acute illness leading to decrease in the production of blood cells and harm the gastrointestinal tract. It also results in the damage to cardiovascular health, blood vessels, brain and especially skin. The major factor attributable to the market growth include the high prevalence of cancer patients globally who further opt for the radiation therapy. For instance, as per the International Agency for Research on Cancer, in 2020, there were 19.3 million cases of cancer globally and 10 million died due to cancer. Thus, this surge in the cancer patients is likely to drive the global radiation injury drugs market growth. 

In addition to this, various enduring research and products under clinical trials are the factors for the growth of radiation injury drug market. For instance, BioMimetix drug BX-001 is under clinical phase II trial and is used for the patients with high-grade glioma. However, the drug is also used to provide protection against the damage or injury done by the radiation therapy. Another key factor that significantly impacts the market growth for these drugs include the fact that the radiation injury can cause reduced production of sperm and egg count in male and female respectively. 

Market Coverage

The market number available for – 2021-2028

Base year- 2021

Forecast period- 2022-2028

Segment Covered- 

o By Type

o By Application 

Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape:  Amgen Inc., and BioMimetix JV, LLC, among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How are players addressing challenges to sustain growth?

Where is the investment opportunity?

Global Radiation Injury Drugs Market Report by Segment

By Type

Aerosurf

BMX-001

C-2E2

C-2E5

Des-Asp Angiotensin 1

DG-3

Others

By Application

Ambulatory Surgical Centers

Hospitals and Clinics

Others

Global Radiation Injury Drugs Market Report by Region

North America       

US

Canada

Europe

Germany

UK

France

Spain

Italy

Rest of Europe

Asia-Pacific    

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Latin America

Middle East and Africa